Home | About the Medical Center | Donate or Volunteer | Contact Us
Anna O'Connor is the first neuroblastoma patient to receive a new drug targeted at a genetic mutation linked to the disease. » Learn more
Or call 1-888-UCH-0200
Notice of Privacy Practices | Legal Disclaimer | Contact Us | Site Map
Call HealthLink toll-free at 1-888-UCH-0200. Copyright © 2010 University of Chicago Medical Center. All rights reserved.